How to Tell If Your Vendor’s Claims Are Valid: A Nine Part Series

Part One will cover regression to the mean (RTM). That is the tendency of outliers on the high or low side, over time, to come closer to the average.
Will Cancer Detection Tests Cause the Next Cost Explosion?
Move over, weight loss drugs. The next explosion in costs could be cancer detection tests. Several new tests for cancer are now on the market. Galleri was first on the market, Cologuard has just introduced Cancerguard. Not to be outdone, an outfit called Mito screens for not just cancers, but 800 different conditions/diseases with a […]
Aon’s Report on Lyra is an Excellent Teaching Tool (Part 2)
This is Part Two of the teaching tool that Aon was gracious enough to provide (See Part One here), and consent to our usage. It is part of the Advanced Critical Outcomes Report Analysis (CORA Pro) curriculum, and we have encouraged Validation Institute (VI)-validated entities and individuals to share it with others, to increase the […]
Aon’s Report on Lyra is an Excellent Teaching Tool (Part 1)
Aon’s White Paper detailing Lyra’s “savings” is an excellent teaching tool for those interested in improving their skills in outcomes measurement. Before we get into the content, we would like to make two acknowledgements: We would like to thank Lyra for graciously making this report available to us and other experts at no charge, to […]
Twin Health Outperforms Traditional Care & Legacy Digital Health Solutions, Setting New Standard for Diabetes and Weight Loss
Vitality Earns Validation Institute Endorsement for Vitality Status as a Proven Tool for Risk Segmentation and Dynamic Benefits Design
ValidPoints August-September 2025
ValidPoints August-September Issue: Plausibility Testing Vendor Claims – Part Two,Four Newly Validated Programs,Advisors Hold the Key to Compliance, and More Plausibility Testing Vendor Claims Part two By Al Lewis,Founder & Validator-In-Chief,Validation Institute When a vendor submits a participants-vs-“propensity-matched”-non-participants study for validation, we always add the Limitation that the former will always outperform the latter regardless of the […]
Meru Health validated by Validation Institute for significant healthcare savings
Measuring What Works in Mental Health
Medicine has always aimed to help people heal and return to fuller lives. Advances in modern medicine, especially in fields like surgery, have transformed what’s possible. But when it comes to chronic illness and mental health, progress has been less consistent. Too often, care focuses on symptom management rather than lasting recovery. Many people find […]
Plausibility Testing Vendor Claims, Part Two
When a vendor submits a participants-vs-“propensity-matched”-non-participants study for validation, we always add the Limitation that the former will always outperform the latter regardless of the intervention. How do we know this? In one case, participants dramatically outperformed non-participants even though there wasn’t a program to participate in. This example shows how the participants outperformed the […]
Ciba Health Authenticated by the Validation Institute for Clinical and Financial Outcomes Across Its Integrative Care Program
ValidPoints July 2025
ValidPoints July Issue: Plausibility Testing Vendor Claims – Part One, Ciba Launches New Program, Podcast by Dr. Cristin Dickerson, Documentary by Ethos Benefits, and More Plausibility Testing Vendor Claims Part One Suppose your family is enjoying dinner one night and your daughter’s cellphone rings. She excuses herself, goes in the other room for a few minutes, […]
Plausibility Testing Vendor Claims, Part One
Suppose your family is enjoying dinner one night and your daughter’s cellphone rings. She excuses herself, goes in the other room for a few minutes, comes back out and announces: ‘‘Mom, Dad, I’m going over to Jason’s house tonight to do homework.’’ No doubt you reply: ‘‘Okay, bye. Have a nice time.’’ Ha, ha, good […]
Goldfinch Health Earns ‘Stamp of Approval’ from Validation Institute
Ciba Health Launches Program to Help Patients Transition Off GLP-1 Medications
Inside Green Imaging: A Smarter Approach to Imaging Benefits